KeepItRealistic Friday, 11/17/17 11:37:01 PM Re: None Post # of 12922 $GRCK DD, must read Recently acquired Eqova.com, a Clinical-grade CBD product company exclusive for doctors from doctors. Other $GRCK positives --CBD.co is a brilliant idea and it will garner a lot of attention especially with the MJ ETF the day after Xmas http://www.otcmarkets.com/stock/GRCK/news/Grey-Cloak-Tech--Inc--Announces-Purchase-of-CBD-co-Domain-and-Plans-to-Build-a-CBD-Marketplace?id=175509&b=y --Clinical-grade CBD products in an explosive industry, especially when Cali goes Recreational in Early 18' --Excellent management team with Low float under 150 mil --Notes nearly paid off https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136254600 --Management has to achieve certain revenue milestones in order to receive half of their preferred shares given to them from the Eqova acquisition Check out CEO video https://m.youtube.com/watch?v=MYQxR1dU8Lk&feature=youtu.be Extremely low market cap of under 1 million. New product launch http://m.marketwired.com/press-release/grey-cloak-tech-inc-to-introduce-cannabio-salve-at-mjbizcon-in-las-vegas-otcqb-grck-2240010.htm All PR’s http://www.otcmarkets.com/stock/GRCK/news Free L2 link as its an OTCQB ticker http://www.otcmarkets.com/stock/GRCK/quote Share Structure , very tiny market cap & float for a CDB company http://www.otcmarkets.com/stock/GRCK/profile GRCK Security Details Share Structure Market Value1 $985,391 a/o Nov 17, 2017 Authorized Shares 500,000,000 a/o Nov 07, 2017 Outstanding Shares 140,770,136 a/o Nov 14, 2017 -Restricted Not Available -Unrestricted Not Available Held at DTC Not Available Float 133,823,444 a/o Nov 07, 2017 Par Value 0.001 37% insider ownership ! https://www.otcmarkets.com/financialReportViewer?symbol=GRCK&id=181626 Large insider ownership usually means they will want a substantial increase in the pps. Article on acquisition (Uncompensated) http://psinvestor.com/grey-cloak-delivers-eqova-acquision-with-solid-structure-sets-stage-for-rebound/ Another article https://www.networknewswire.com/strategic-acquisition-enables-grey-cloak-tech-inc-s-grck-development-two-industries/ Recently Uplisted to OTCQB, Audited Cancelled RS - Insiders and 5% stakeholders own around 168 million shares of common stock Company is targeting a niche market with products ready to sell and an experienced management team who own 90 million shares (skin in the game). See form 4 & 3’s Warrants at .25 Strong following on Twitter (74,000) https://twitter.com/greycloaktech/status/923193652700176384 Eqova are Clinical-grade CBD products. “Eqova's products are created using full spectrum hemp oil and other ingredients to achieve standardized dosing. These formulations combine the scientifically validated, powerful benefits of cannabinoids in standardized products, which are then distributed to patients under the care of licensed health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing clinical-grade products made in cGMP Compliant Labs located in the United States. Hypothetical future pps potential based on sector sentiment. conservatively .25+ within first quarter of 2018 based on other tickers in the same sector trading today. Much higher is very plausible later in 2018 Reminder of some current facts - float is less than 150 million - insider ownership is 37% - Market cap is under 1 mllion - CBD products are ready to sell At .10 our market cap would be 15 mil At .20 our market cap would be 30 mil At .50 our market cap would be 75 mil The sector: MJNA has a 300 million market cap and if you look at their description, they do CBD products. Clearly extremely under valued at under 1 million market.